Skip to main content
. Author manuscript; available in PMC: 2017 Jun 15.
Published in final edited form as: Neuron. 2016 Jun 15;90(6):1154–1163. doi: 10.1016/j.neuron.2016.05.040

Figure 6.

Figure 6

Genetics can be applied as a tool to facilitate therapeutic trials and ultimately treatment. This includes genetic identification of at risk individuals, use in defining biomarkers, and defining sub-types of both disease and response to treatment. It can also be used as part of the process of identifying people in the prodrome of the disease before clinical symptoms become apparent, which is precisely when one would want to start mechanistic treatment.